Trial intelligence / Profile preview

Exercise vs Dopamine Agonists for RLS in Hemodialysis

NCT06468371Completed

Sponsor
Lahore General Hospital
Start
Jan 2022
Primary completion
Dec 2023
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Lahore General Hospital. Primary endpoint: Change in the International Restless Legs Syndrome Study Group score at 3 months. Started Jan 2022; status: completed.

Beyond the preview

Go deeper on NCT06468371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06468371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call